Nicole Torres, a spokeswoman for the Office of Emergency Management for the city of Annapolis, Md., ties a sandbag on Friday, Sept. 22, 2022 as residents prepared for an approaching storm. (AP Photo/Brian Witte)
By Sarah Brumfield and Brian Witte
Tropical Storm Ophelia formed off the mid-Atlantic coast and was expected to bring heavy rain, storm surge and windy conditions over the weekend, the National Hurricane Center said Friday.
Ophelia had maximum sustained winds of 60 mph (95 kph), according to a 2 p.m. advisory from the Miami-based center. The storm was centered 150 miles (240 kilometers) southeast of Cape Fear, North Carolina, and was forecast to make landfall Saturday morning.
Virginia’s governor declared a state of emergency Friday and the intensifying weather system forced schools to close early and canceled weekend events.
Rain was already moving inland across North Carolina by midday Friday with some areas expected to get up to 7 inches (17.7 centimeters) across eastern parts of the state and into southeast Virginia, forecasters said. Storm surge warning was in effect for some areas, with surges between 3 and 5 feet (0.9 to 1.5 meters) forecast for parts of North Carolina, the hurricane center reported.
The system’s center is expected to move inland over eastern North Carolina and southeastern Virginia and near the Chesapeake Bay through Sunday, Mike Brennan, the hurricane center’s director, said in a livestreamed briefing on Friday.
A storm surge warning was in effect from Beaufort Inlet, North Carolina, to Chincoteague, Virginia, and a tropical storm warning was issued from Cape Fear, North Carolina to Fenwick Island, Delaware.
Nancy Shoemaker and her husband Bob stopped by a waterside park in downtown Annapolis, Maryland's capital, to pick up sandbags to help protect their waterfront home.
Last year, at the end of October, they experienced a big surge of water that came into their yard and even washed some sandbags away.
“We’re hoping it won’t be that way this time,” Nancy Shoemaker said. “If we have a lot of wind and a lot of surge, it can look like the ocean out there, so that’s a problem.”
The weather was already affecting water taxis in Annapolis, where water taxi driver Scott Bierman said service would shut down at 6 p.m., and the decision had already been made to close Saturday.
“We don’t operate when it’s going to endanger passengers and or damage vessels,” Bierman said.
Virginia Gov. Glenn Youngkin declared a state of emergency Friday afternoon, issuing an executive order intended to ease response and recovery efforts.
“As this storm has organized and strengthened, it’s becoming clear based on the latest forecasts that impacts to the commonwealth are likely,” Youngkin said in a statement. “We want to ensure that all communities, particularly those with the greatest anticipated impact, have the resources they need to respond and recover from the effects of this storm.”
The governor encouraged residents to prepare an emergency kit and follow the weather forecast closely.
Schools in coastal areas of North Carolina and Virginia announced plans to dismiss students early Friday and cancel afterschool and weekend activities.
The North Carolina Ferry System announced it was suspending several routes and the State Emergency Response Team planned to move to an enhanced watch Friday to ease coordination of resources, the governor’s office said.
The forecast prompted the cancellation of events across the region, including the Kunta Kinte Heritage Festival, which had been set to return to City Dock in Annapolis on Saturday.
Meanwhile, Hurricane Nigel was downgraded to a post-tropical cyclone centered about 640 miles (1,030 kilometers) northwest of the Azores with maximum sustained winds of 70 mph (110 kph). There were no associated coastal watches or warnings as the storm moved northeast at 37 mph (59 kph), the hurricane center said in its final update on the system Friday morning.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
